Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-24-035887

Chief Scientific Officer sold 6,190 shares at an average $16.38 ($101,421)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lorrain Daniel S. · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-18 Sale : show line 1 in the form 10b5-1 −6,091 $16.37 $99,733 169,671 D
2024-11-18 Sale : show line 2 in the form 10b5-1 −99 $17.05 $1,688 169,572 D
Open-market sales · 6,190 sh · avg $16.38 · $101,421
Loading xslF345X05/rdgdoc.xml…